Lumature Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.42M Sell
3,030
-53
-2% -$22.2K 0.84% 29
2023
Q1
$1.06M Sell
3,083
-465
-13% -$157K 0.59% 38
2022
Q4
$1.3M Sell
3,548
-221
-6% -$78.4K 0.73% 31
2022
Q3
$1.22M Sell
3,769
-211
-5% -$66.9K 0.65% 32
2022
Q2
$1.29M Sell
3,980
-724
-15% -$217K 0.57% 37
2022
Q1
$1.35M Buy
4,704
+671
+17% +$173K 0.54% 46
2021
Q4
$1.11M Buy
4,033
+164
+4% +$41.6K 0.43% 51
2021
Q3
$894K Buy
3,869
+289
+8% +$71.3K 0.37% 62
2021
Q2
$822K Buy
3,580
+297
+9% +$59.7K 0.34% 63
2021
Q1
$613K Buy
+3,283
New +$642K 0.32% 70

Other funds holding LLY

Lumature Wealth Partners's LLY Position: Q2 2023 in Review

Lumature Wealth Partners reduced its Eli Lilly (LLY) stake by 1.7% in Q2 2023, selling an estimated $22.2K and leaving 3,030 shares worth $1.42M. The position accounts for 0.84% of the portfolio, ranked #29.

Lumature Wealth Partners first reported a position in LLY in Q1 2021 and has held it in 10 quarters since. 2,815 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Lumature Wealth Partners held 3,030 shares of Eli Lilly worth $1.42M as of Q2 2023.
  • Lumature Wealth Partners sold 53 Eli Lilly shares in Q2 2023, an estimated $22.2K.
  • Eli Lilly made up 0.84% of Lumature Wealth Partners's portfolio in Q2 2023, its #29 holding.
  • Lumature Wealth Partners first reported a position in Eli Lilly in Q1 2021 and has held it in 10 quarters since.
  • 2,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.